Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse

		Keywords:		Glioblastoma Multiforme, XL184

		Phase:		Phase 2

		Treatment ID#s:		VT1885

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Recurrent Glioblastoma first or 2nd progression

		Last Updated:		06/29/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		U. Of California At San Francisco Michael Prados, MD Professor Contact: Dr. Michael Prados 400 Parnassus Avenue, Rm A808 San Francisco, CA 94143- Phone:(415)353-2966 Fax: (415)353-2167 Click here to send an email Website: neurosurgery.medschool.ucsf.edu/index.html University of Virginia Health System David Schiff, MD Co-Director, Division of Neuro-Oncology Department of Neurology Box 800432 Charlottesville, VA 22908-0432 Phone:434-982-4415 Fax: 434-982-4467 Click here to send an email Website: www.uvabraintumor.com

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By